cystic fibrosis

Cystic fibrosis treatment from Cary firm offers relief to adults afflicted with disease

Posted by WRAL TechWire | Mar 23, 2021

Adults living with cystic fibrosis (CF) now have access to a new revolutionary therapy aimed at improving pulmonary function. Here are the details.

Raleigh biotech startup Arrevus gets FDA support for its drug treating cystic fibrosis patients

Posted by WRAL News | Jan 28, 2020

Arrevus today announced the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) Designation for ARV-1801 (sodium fusidate tablet) for the treatment of pulmonary exacerbations in CF patients.

Chapel Hill startup lands rights to drug offering hope to cystic fibrosis patients

Posted by WRAL News | Aug 21, 2019

The firm received the license from Laurel Therapeutics, a global clinical-stage biopharmaceutical company in Hangzhou China. PBA will use its proprietary technology – an organoid platform using primary cells — to identify subpopulations of patients in which the drug candidate is effective.

Durham-based Spyryx raises $5.9 million from seven investors

Posted by WRAL TechWire | Oct 5, 2018

Biotechnology company Spyryx Biosciences has raised $5.9 million to fund its working capital and compensate its executive officers.

Icagen raises $7.25M, bringing its total to $20.75M for 2018

Posted by WRAL TechWire | Sep 17, 2018

Drug development company Icagen Inc. raised $7.25 million from one investor, according to a securities filing.

Durham-based pharma firm Renovion raises $350,000

Posted by WRAL TechWire | May 16, 2018

Renovion, a pre-clinical stage pharmaceutical company based in Durham, has raised $350,000 in a private equity offering, according to a securities filing.